Morgan Stanley’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-62,273
| Closed | -$10.9K | – | 7929 |
|
|
2022
Q4 | $10.9K | Sell |
62,273
-14,057
| -18% | -$2.46K | ﹤0.01% | 6901 |
|
|
2022
Q3 | $33K | Sell |
76,330
-34,770
| -31% | -$15K | ﹤0.01% | 6589 |
|
|
2022
Q2 | $94K | Sell |
111,100
-161,637
| -59% | -$137K | ﹤0.01% | 6309 |
|
|
2022
Q1 | $1.5M | Buy |
272,737
+4,655
| +2% | +$25.6K | ﹤0.01% | 4723 |
|
|
2021
Q4 | $2.6M | Buy |
268,082
+143,359
| +115% | +$1.39M | ﹤0.01% | 4364 |
|
|
2021
Q3 | $2.23M | Buy |
124,723
+1,861
| +2% | +$33.3K | ﹤0.01% | 4480 |
|
|
2021
Q2 | $3M | Buy |
122,862
+84,506
| +220% | +$2.06M | ﹤0.01% | 4295 |
|
|
2021
Q1 | $1.02M | Sell |
38,356
-16,943
| -31% | -$449K | ﹤0.01% | 4721 |
|
|
2020
Q4 | $419K | Buy |
55,299
+30,371
| +122% | +$230K | ﹤0.01% | 5186 |
|
|
2020
Q3 | $125K | Sell |
24,928
-195,267
| -89% | -$979K | ﹤0.01% | 5332 |
|
|
2020
Q2 | $1.32M | Buy |
220,195
+158,621
| +258% | +$949K | ﹤0.01% | 3947 |
|
|
2020
Q1 | $273K | Sell |
61,574
-42,687
| -41% | -$189K | ﹤0.01% | 4732 |
|
|
2019
Q4 | $991K | Sell |
104,261
-33,521
| -24% | -$319K | ﹤0.01% | 4533 |
|
|
2019
Q3 | $1.08M | Buy |
137,782
+61,637
| +81% | +$484K | ﹤0.01% | 4250 |
|
|
2019
Q2 | $1.2M | Sell |
76,145
-8,102
| -10% | -$127K | ﹤0.01% | 4129 |
|
|
2019
Q1 | $1.53M | Buy |
84,247
+25,888
| +44% | +$469K | ﹤0.01% | 3814 |
|
|
2018
Q4 | $939K | Buy |
58,359
+1,750
| +3% | +$28.2K | ﹤0.01% | 4322 |
|
|
2018
Q3 | $1.36M | Buy |
+56,609
| New | +$1.36M | ﹤0.01% | 4302 |
|